Early signs Monitoring to Prevent relapse and prOmote Wellbeing, Engagement and Recovery: a mixed methods study

HS Greater Glasgow & Clyde0 个研究点目标入组 149 人开始时间: 2015年12月21日最近更新: 2022年6月20日

适应症

试验速览

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31651400 qualitative study results (added 29/10/2019) 2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31821154 process evaluation protocol (added 11/12/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31826793 qualitative investigation results (added 13/12/2019) 2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31917372 protocol (added 10/01/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35569503/ (added 16/05/2022) 2022 Funder report results in https://pubmed.ncbi.nlm.nih.gov/35639493/ results and plain language summary in Health Technology Assessment (added 08/06/2022)

•Service users of participating CMHT's:
•1. Aged 16 years or over
•2. In contact with a local community based services
•3. Have been admitted to a psychiatric in-patient service at least once in the previous two years for a relapse of psychosis
•4. A diagnosis of schizophrenia spectrum disorder (DSM-V)
•5. Able to provide informed consent as adjudged by the care co-ordinator or if in doubt the responsible consultant.
•Carers who are nominated by eligible service users who provide informed consent will also be approached for their inclusion in the study. Service users can also nominate proxy-carers if they do not have a trusted other (e.g., care co-ordinator, keyworker, support worker).

发起方

HS Greater Glasgow & Clyde